Deciphera Pharmaceuticals, Inc. DCPH
25.59 +25.59
Day range unavailable
52-week range unavailable
DCPH revenue history
Revenue is income from the company’s ordinary business activities.
163,356,000 USD
FY 2023 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2023 | 2023-12-31 | 163,356,000 | 29,320,000 | 21.87% |
| FY 2022 | 2022-12-31 | 134,036,000 | 37,888,000 | 39.41% |
| FY 2021 | 2021-12-31 | 96,148,000 | 54,061,000 | 128.45% |
| FY 2020 | 2020-12-31 | 42,087,000 | 17,087,000 | 68.35% |
| FY 2019 | 2019-12-31 | 25,000,000 | 25,000,000 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | 0 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | 0 | Not meaningful |
| FY 2015 | 2015-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:17.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.